Sitemap

Why We Invested in DevAssure?

4 min readApr 22, 2025

Product teams race to ship new features every sprint, yet quality pipelines lag behind. Traditional automation (low‑code record tools or heavyweight Selenium frameworks) forces an impossible choice between velocity and stability. DevAssure eliminates that trade‑off by weaving intelligent agents into every commit. Here’s why we invested.

The Quality Gap in Modern Software Delivery

Continuous delivery now lets product teams push code to production almost as quickly as a developer can hit commit, but quality pipelines have not kept pace. Feature velocity compounds each sprint while test coverage still expands by manual effort. Early‑stage teams reach for low‑code “record and play” utilities, only to see them fail on real‑world flows like one‑time‑password verification or responsive layouts. Mature teams jump to the opposite extreme, building custom Selenium or Playwright frameworks that swallow quarters of engineering time and leave a maintenance tax on every release. Either way, organisations face an ugly binary: slow the roadmap to protect quality or ship on time and hope the defect tracker stays quiet.

The price shows up on the income statement, not just the sprint board. Estimates indicate that a bug caught in production costs 35x more to fix than one found during design. Companies still learn that lesson the hard way: a single checkout failure can erase a day’s revenue, and a misplaced permissions flag can trigger fines that dwarf the engineering budget. Meanwhile, the small group who built the test harness become de‑facto gatekeepers. When they leave, the tribal knowledge of the framework leaves with them. The founders of DevAssure lived this cycle at Ally.io, where a neat suite of “happy‑path” tests ballooned into thousands of brittle scripts that dragged behind the product. The pattern was repeated after Microsoft acquired Ally.io, but only at the cloud scale.

DevAssure’s Thesis: Autonomous End‑to‑End Test Orchestration

DevAssure attacks the bottleneck by turning testing into an autonomous fabric woven through the delivery pipeline. The platform is a constellation of AI agents, each owning a part of the lifecycle. One agent parses Figma files and spec documents to draft exhaustive edge‑case suites before code exists. A second agent sits in VS Code, watches each commit, and flags UI elements that diverge from those specs. A third agent transforms approved cases into executable scripts, then heals those scripts when selectors drift. All activity runs inside the customer’s CI pipeline or locally when policy demands, avoiding the cloud‑only lock‑in that excludes many QA vendors from fintech and healthcare.

Early pilots show the lift when agent speed meets on‑prem pragmatism. One digital bank cut its test‑creation effort from ten engineer‑days to two. A B2B SaaS customer trimmed onboarding time by 80%. Another beta client reports interns automating more cases in an hour than senior testers produced in a week using Selenium. Fewer dedicated QA hires, near‑instant pull‑request feedback and release cadences that stay weekly without widening the blast radius translate directly to margin.

Founders with Scar Tissue and Range

Badri Varadarajan, Divya Manohar, and Santhosh Selladurai do not romanticise testing; they have fought its trench warfare. Badri scaled Ally.io’s QA function from zero to 35 engineers and shepherded it through Microsoft’s acquisition diligence. Divya ran site reliability and incident response for a multi‑tenant SaaS stack, where uptime targets left no margin for flaky tests. Santhosh built bespoke automation harnesses whose upkeep eventually eclipsed their benefit. Five years of working together forged a common thesis: testing must be embedded, adaptive, and invisible to stay relevant. Reference calls echo the same theme. The team speaks the language of testers yet designs like product engineers, which makes DevAssure credible to CTOs and approachable to manual QAs.

Where the Wedge Appears

Dev‑tool defensibility rests on three pillars: deep context, workflow presence and a self‑reinforcing data loop.

  • Context
    DevAssure’s hybrid architecture keeps tests and data inside the customer’s build environment. That design decision removes the security objection that blocks cloud‑only incumbents.
  • Workflow presence
    DevAssure makes testing a keystroke, not a separate dashboard, by surfacing test commands directly within the code editor. Adoption no longer depends on a QA champion, and cultural resistance fades.
  • Data loop
    A forthcoming observability agent will mine production logs, infer real user paths and feed them back into the test‑case generator. The suite grows smarter every release, a feedback cycle few rivals even contemplate.

Together, these pillars turn an initial tool into sticky, permissioned infrastructure that is increasingly hard to displace.

Market Timing

Global spend on software quality, tools, and labour already tops $40B annually, yet workflows remain stubbornly manual. GenAI opens a new curve: agents that understand intent, watch for drift and adjust tests autonomously. Selenium and Playwright still assume infinite engineer hours. Scriptless recorders help only on trivial flows. DevAssure steps in where complexity begins — mobile apps, compound authentication, component libraries that morph each sprint — and it does so without forcing a wholesale migration to a vendor cloud. Early demand clusters around security‑sensitive verticals such as fintech and healthtech, and design‑led SaaS companies chasing weekly releases.

Why We Invested

At Eximius Ventures, we back software that erases a trade‑off (in this case, speed versus quality) and then embeds itself so deeply that leaving feels reckless. DevAssure aligns with three macro shifts we track: agent‑driven developer tooling, the mandate to run lean engineering teams and the regulatory swing back to self‑hosted pipelines. The founders’ domain scars give them authenticity, and their roadmap gives them leverage.

Design partners capture the sentiment better than we could: “This finally lets us release on Fridays without holding our breath.” When a platform makes shipping faster and safer, the only question is how quickly the market adopts it. We believe that inflection is imminent, and we are excited to partner with DevAssure as they turn autonomous test orchestration from a promising demo to an industry default.

--

--

Eximius Ventures
Eximius Ventures

Written by Eximius Ventures

Investing in Founders from Ideation to Execution

No responses yet